On Thursday, Shares of Skechers USA Inc. (NYSE:SKX), gained 14.54% to $86.87, hitting its highest level.
Skechers, declared financial results for the first quarter ended March 31, 2015.
First quarter 2015 net sales were $768.0 million contrast to $546.5 million in the first quarter of 2014, an enhance of 40.5 percent. Gross profit for the first quarter of 2015 was $332.5 million, or 43.3 percent of net sales, contrast to $240.4 million, or 44.0 percent of net sales in the first quarter of 2014. Earnings from operations for the first quarter of 2015 were $88.2 million, or 11.5 percent of net sales, contrast to net earnings from operations of $48.2 million, or 8.8 percent of net sales, for the first quarter of 2014.
Net earnings in the first quarter of 2015 were $56.1 million contrast to net earnings of $31.0 million for the first quarter of 2014. Net earnings per diluted share in the first quarter 2015 were $1.10 based on 51.1 million weighted average shares outstanding contrast to a diluted net earnings per share of $0.61 based on 50.8 million weighted average shares outstanding for the same period in the preceding year.
Skechers U.S.A., Inc. designs, develops, markets, and distributes footwear for men, women, and children, in addition to performance footwear for men and women under the Skechers GO brand name. It operates through four segments: Domestic Wholesale Sales, International Wholesale Sales, Retail Sales, and E-commerce Sales.
Shares of Uranium Energy Corp. (NYSEMKT:UEC), gained 13.21% to $2.40, during its last trading session, hitting its highest level, after a Japanese court decided to remove one of the last noteworthy roadblocks in the way of restarting Kyushu Electric Power’s Sendai nuclear power plant.
On Wednesday, a Kagoshima District Court rejected a petition filed by some residents near the plant in the city of Satsumasendai to delay the restart of two reactors after safety regulators cleared it.
All 48 of Japan’s nuclear reactors were taken offline following the Fukushima disaster in 2011. About 30% of Japan’s energy was nuclear generated preceding to Fukushima.
Japanese Prime Minister Shinzo Abe has been pushing to restart the nation’s nuclear industry with a aim of sourcing 20% of the nation’s electricity needs from nuclear power by 2030.
Japan’s restarting of its nuclear power plants would likely boost uranium prices, as investors would feel more confident in the uranium industry.
Uranium Energy Corp. engages in the exploration, extraction, and processing of uranium concentrates on projects located in the United States and the Republic of Paraguay. As of July 31, 2014, it had mineral rights in uranium projects located in the states of Arizona, Colorado, New Mexico, Texas, and Wyoming, in addition to in the Republic of Paraguay.
At the end of Thursday’s trade, Shares of Sysorex Global Holdings Corp. (NASDAQ:SYRX), gained 11.96% to $2.34.
Sysorex Global Holdings, declared that its Lilien Systems division has been selected as one of the 65 Prime Contract Holders under the Chief Information Officer – Commodities and Solutions (CIO-CS) contract by National Institutes of Health Information Technology Acquisition and Assessment Center (NITAAC).
CIO-CS, a multiple-award Government-Wide Acquisition Contract (GWAC), is a 10 year Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a maximum value of $20 billion with a one 60-month base period from May 1, 2015 to April 30, 2020; and one 60-month option period from May 1, 2020 to April 30, 2025. As a CIO-CS Prime Contract Holder, Lilien is among a handful of companies allowed to fulfill task orders from federal, civilian or DoD agencies seeking to acquire IT commodities and solutions.
The CIO-CS contract is Sysorex’s third such contract award in the past two months. In March, Sysorex was awarded a subcontract on the $249 million Enterprise Information Technology Services (EITS) contract from the US Army. In early April, it received an award on the NASA SEWP V contract.
Sysorex Global Holdings Corp., through its auxiliaries, provides data analytics and location based solutions and services to commercial and government customers worldwide. It operates through four segments: IT Commercial, IT Government, eSolutions, and Location-Based Technology.
Finally, Cerus Corporation (NASDAQ:CERS), ended its last trade with 11.83% gain, and closed at $4.58.
Cerus Corporation, declared that its first quarter results will be released on Tuesday, May 5, 2015, after the close of the stock market. The company will host a conference call and webcast at 4:15 PM ET that afternoon, during which administration will talk about the Company’s financial results and provide a general business overview and outlook.
Cerus Corporation operates as a biomedical products company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System is based on its proprietary technology for controlling biological replication and designed to target and inactivate blood-borne pathogens, counting viruses, bacteria, and parasites, in addition to potentially harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, and red blood cell transfusion products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
